Suscribirse

Long-Term Health-Related Quality of Life in Working-Age COVID-19 Survivors: A Cross-Sectional Study - 17/07/24

Doi : 10.1016/j.amjmed.2024.05.016 
Hiten Naik, MD, SM a, b, c, , James Wilton, MPH e, Karen C. Tran, MD, MHSc a, b, d, Naveed Zafar Janjua, MBBS, DrPH d, e, f, Adeera Levin, MD a, b, d, Wei Zhang, PhD c, d
a Department of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada 
b Post-COVID-19 Interdisciplinary Clinical Care Network, Provincial Health Services Authority, Vancouver, British Columbia, Canada 
c Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, British Columbia, Canada 
d Centre for Advancing Health Outcomes, Vancouver, British Columbia, Canada 
e BC Centre for Disease Control, Provincial Health Services Authority, Vancouver, British Columbia, Canada 
f School of Population and Public Health, The University of British Columbia, Vancouver, British Columbia, Canada 

Requests for reprints should be addressed to Hiten Naik, MD, SM, The University of British Columbia Clinician Investigator Program, Suite 200 City Square East Tower South, 555 W. 12th Avenue, Vancouver, BC V5Z 3X7, Canada.The University of British Columbia Clinician Investigator ProgramSuite 200 City Square East Tower South 555 W. 12th AvenueVancouverBCV5Z 3X7Canada

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

En prensa. Pruebas corregidas por el autor. Disponible en línea desde el Wednesday 17 July 2024

Abstract

Background

Most working-age (18-64) adults have been infected with SARS-CoV-2, and some may have developed post-COVID-19 condition (PCC). However, long-term health-related quality of life (HRQOL) following infection remains uncharacterized.

Methods

In this cross-sectional study, COVID-19 survivors from throughout British Columbia (BC), Canada, completed a questionnaire >2 years after infection. PCC status was self-reported, and HRQOL was assessed using the EuroQol 5-dimension 5-level (EQ-5D-5L) instrument. We compared HRQOL in those with current PCC, those with recovered PCC, and those without a history of PCC. Multivariable analyses were weighted to be representative of COVID-19 survivors in BC.

Results

Of the 1,135 analyzed participants, 19.2% had current PCC, and 27.6% had recovered PCC. Compared to those without a history of PCC, participants with recovered PCC had a similar mean EQ-5D health utility (adjusted difference -0.02 [95%CI -0.03, 0.00]), but those with current PCC had a lower health utility (adjusted difference -0.08 [95%CI -0.12, -0.05]). Participants with current PCC were also more likely to report problems with mobility (adjusted odds ratio (aOR) 6.00 [95%CI 2.88-12.52]), self-care (aOR 5.96 [95%CI 1.84-19.32]), usual activities (aOR 8.00 [95%CI 4.27-14.99]), pain/discomfort (aOR 4.28 [95%CI 2.46-7.48]), and anxiety/depression (aOR 3.45 [95%CI 1.90-6.27]).

Conclusions

In working-age adults who have survived >2 years following COVID-19, HRQOL is high among those who never had PCC or have recovered from PCC. However, individuals with ongoing symptoms have lower HRQOL and are more likely to have functional deficits. These findings underscore the importance of implementing targeted healthcare interventions to improve HRQOL in adults with long-term PCC.

El texto completo de este artículo está disponible en PDF.

Keywords : Activities of daily living, COVID-19, Employment, Post-acute COVID-19 syndrome, SARS-CoV-2, Cross-sectional study, Health-related quality of life


Esquema


 Funding: HN is supported by The University of British Columbia Clinician Investigator Program and a CAN-TAP-TALENT & Michael Smith Health Research BC Postdoctoral Fellowship. WZ has been supported by a Michael Smith Health Research BC Scholar award. This study was funded in part by the St. Paul's Foundation and British Columbia Ministry of Health.
 Conflict of Interest: HN is a member of the Canadian Guidelines for Post-COVID-19 Condition Guideline Team for Pharmacologic and Nonpharmacologic Clinical Interventions.
 Role of Funder: The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.


© 2024  Publicado por Elsevier Masson SAS.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.